Niger

in page functions
[French]
Niger
Total population (2017) 21,563,603
Birth cohort (2017) 1,054,269
Surviving Infants (surviving to 1 year per year, 2017) 1,000,128
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 57/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 96/1000
World Bank Index, IDA (2015) 3.46
Gross Nation Income (per capita US$, 2015) 390
Co-financing group (2017) Initial self-financing
No. of districts/territories (2016) 44

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Niger

Type of support

Approvals

2001-2021 (US$)
(23 Aug 2017)

Commitments

2001-2021 (US$)
(23 Aug 2017)

Disbursements

2000-2017 (US$)
(23 Aug 2017)

% Disbursed

(23 Aug 2017)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $159,904,423 $231,163,909 $150,991,955
Cash Support (CASHSUPP) $235,000 $260,000 $235,000 100%
Cold Chain Equipment Optimisation Platform (CCEOP) $2,984,274 $2,984,274
Health system strengthening (HSS 1) $3,533,902 $3,533,902 $3,533,902 100%
Health system strengthening (HSS 2) $24,792,106 $40,025,092 $17,164,564 69%
HPV Demo (NVS) $599,142 $599,142 $610,200 102%
Immunisation services support (ISS) $7,398,724 $7,398,724 $7,398,724 100%
Injection Safety Devices (NVS) $297,000 $1,484,000 $313,326 105%
Injection safety support (INS) $943,757 $943,757 $943,757 100%
IPV (NVS) $2,264,617 $2,264,617 $2,103,346 93%
Meningitis A (NVS) $352,500 $1,890,000 $382,591 109%
Meningitis A - mini catch-up campaign (NVS) $4,905,500 $4,905,500 $5,099,371 104%
Meningitis A - mini catch-up op.costs (OPC) $3,802,456 $3,802,456
Penta (NVS) $43,711,734 $52,186,234 $43,556,747 100%
Pneumo (NVS) $41,865,177 $72,495,677 $47,984,871 115%
Product Switch Grant (PSG) $240,500 $240,500
Rotavirus (NVS) $13,549,742 $24,618,742 $13,619,716 101%
Vaccine Introduction Grant (VIG) $3,594,000 $3,594,000 $2,825,500 79%
Yellow Fever (NVS) $4,834,292 $7,937,292 $5,220,340 108%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Niger DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 92%
M:F sex ratio at birth (2017) 1.05
Household survey: DTP3 coverage for male (2011) 67.50%
Household survey: DTP3 coverage for female (2011) 68.60%
Household survey: Last DTP3 survey (2011) 68%
% districts achieving > 80% DTP3 coverage (2016) 89%
% districts achieving < 50% DTP3 coverage (2016) 0%
MCV WHO/UNICEF estimates (2016) 74%

Breakdown of support

Non-vaccine support Vaccine support
21% 79%
$32,101,447 $118,890,508

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Niger

25 April 2017

Central African Republic, a mother and her two children.

Central African Republic: mother spreads word about meningitis A vaccine

Izimili Raude knows that her community must rely on vaccines, not miracles, to spare children from a deadly disease.

19 September 2016

Stockpiling

On the frontline: Gavi's support to fragile states

With more than half of Gavi-supported countries officially listed as fragile states, Gavi is increasingly working on several fronts to ensure vaccines still reach people living on the frontlines of humanitarian crises.

27 July 2016

First Sudanese child to receive Meningitis A vaccine as part of routine immunization.

Sudan: first to introduce life-saving meningitis A vaccine into routine immunization

Children in Sudan are set to become the first in the Meningitis belt to benefit from the introduction of Meningitis A vaccine into a routine immunization programme.

close icon

modal window here